ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
6.00
-1.25 (-17.24%)
Nov 9, 2026, 11:13 AM EST
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $24.91 million as of November 9, 2026. It is the 32,818th most valuable company in the world and the 4,841st biggest in the United States. Its market cap has decreased by 55.10% in one year.
Market Cap
24.91M
Enterprise Value
25.67M
Revenue
209.03K
Global Rank
Country Rank
#4,841 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 24.91M, an increase of 932.17%. That is a compound annual growth rate of 10.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 43.55M | 27.07% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProText Mobility | 66.81M |
| Nuo Therapeutics | 51.82M |
| Sangamo Therapeutics | 47.23M |
| Arch Biopartners | 42.12M |
| Cell Source | 35.80M |
| Provectus Biopharmaceuticals | 22.27M |
| Biomind Labs | 19.41M |
| Vicapsys Life Sciences | 16.19M |